MarketCap
Facebook
X
Telegram
Organovo Holdings ROA Ratio | ONVO
Annual ROA Ratio Organovo Holdings
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -187.42 | -16.98 | -231.08 | -84.97 | -34.38 | -42.15 | -65.79 | -65.57 | -69.85 | -55.58 | -57.08 | -56.24 | -51.5 | -92.75 | -260.03 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -16.98 | -260.03 | -91.42 |
Quarterly ROA Ratio Organovo Holdings
| 2027-Q1 | 2026-Q4 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -127.17 | -88.67 | -178.35 | -177.42 | -186.46 | -162.72 | -203.31 | -149.42 | -138.98 | -103.66 | -116.68 | -88.0 | -62.74 | -35.44 | -45.41 | -58.98 | -53.69 | -43.16 | -49.51 | -51.17 | -36.75 | -65.07 | -68.47 | -67.59 | -64.35 | -43.91 | -49.74 | -55.1 | -61.19 | -59.65 | -59.03 | -57.45 | -59.07 | -62.49 | -62.95 | -60.98 | -61.01 | -60.69 | -58.26 | -59.7 | -55.85 | -52.23 | -55.13 | -54.53 | -54.1 | -60.56 | -57.5 | -54.16 | -77.07 | -155.77 | -235.72 | -282.74 | -319.03 | -670.01 | -907.12 | -853.11 | -1092.67 | -648.85 | -630.09 | -311.13 | -4.75 | -311.13 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -4.75 | -1092.67 | -165.12 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Neuronetics
STIM
|
-27.55 | $ 2.93 | 1.74 % | $ 193 M |  USA |
 |
Thermo Fisher Scientific
TMO
|
6.09 | $ 603.02 | 0.02 % | $ 227 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 128.06 | 2.68 % | $ 7.66 B | USA |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 9.33 | 5.97 % | $ 389 M | USA |
 |
Sotera Health Company
SHC
|
2.39 | $ 18.59 | 0.05 % | $ 5.28 B | USA |
 |
VolitionRx Limited
VNRX
|
-338.45 | $ 0.33 | 2.52 % | $ 41.5 M |  Singapore |
 |
Waters Corporation
WAT
|
12.66 | $ 402.91 | 0.33 % | $ 24 B | USA |
 |
Exagen
XGN
|
-34.39 | $ 7.3 | 0.53 % | $ 157 M | USA |
 |
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 9.06 | 0.64 % | $ 3.25 B |  Irlanda |
 |
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Psychemedics Corporation
PMD
|
-22.37 | - | -1.84 % | $ 15.3 M | USA |
 |
Quotient Limited
QTNT
|
-64.5 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 235.5 | 0.06 % | $ 26.1 B | USA |
 |
Syneos Health
SYNH
|
3.25 | - | - | $ 4.46 B | USA |
 |
T2 Biosystems
TTOO
|
-143.91 | - | -39.35 % | $ 313 K | USA |
 |
Meridian Bioscience
VIVO
|
9.17 | - | - | $ 1.49 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K |  Israel |
 |
Brainsway Ltd.
BWAY
|
3.1 | $ 14.16 | 0.07 % | $ 481 M | Israel |
 |
Renalytix AI plc
RNLX
|
-419.67 | - | 5.66 % | $ 22.7 M |  Britain |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Quidel Corporation
QDEL
|
43.3 | $ 13.38 | 0.29 % | $ 564 M | USA |
 |
Precipio
PRPO
|
-1.7 | $ 27.25 | 0.11 % | $ 43.7 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | Britain |
 |
Anixa Biosciences
ANIX
|
-67.95 | $ 2.9 | 0.66 % | $ 94.1 K | USA |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
|
Biodesix
BDSX
|
-40.31 | $ 26.63 | 1.72 % | $ 201 M | USA |
 |
Biomerica
BMRA
|
-55.85 | $ 2.34 | 1.3 % | $ 6.82 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.2 | 1.25 % | $ 6.53 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-6.75 | $ 10.71 | 11.22 % | $ 113 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Agilent Technologies
A
|
10.24 | $ 146.85 | 0.59 % | $ 41.7 B | USA |
|
Centogene N.V.
CNTG
|
-46.05 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-83.11 | - | 0.12 % | $ 80.1 M | China |
 |
Bioventus
BVS
|
3.33 | $ 13.83 | 0.42 % | $ 921 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 50.31 | 2.05 % | $ 2.68 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 93.02 | 0.75 % | $ 4.35 B | USA |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 1.12 | 2.55 % | $ 1.49 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 280.76 | 0.54 % | $ 13.9 B | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 32.76 | 1.03 % | $ 950 M | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 205.23 | 0.53 % | $ 146 B | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 7.03 | 3.72 % | $ 28 M | Israel |
 |
DexCom
DXCM
|
13.19 | $ 84.53 | 0.02 % | $ 33 B | USA |
 |
Fulgent Genetics
FLGT
|
-4.99 | $ 20.2 | 2.38 % | $ 622 M | USA |